Nexus Surgical and Medicare Ltd Financials
Company Logo

Nexus Surgical and Medicare Ltd Financial Statement

Nexus Surgical and Medicare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue1.76
Operating Expense1.64
Net Profit0.09
Net Profit Margin5.11
Earning Per Share0.16
EBIDTA0.12
Effective Tax Rate25.00

Nexus Surgical and Medicare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual3.47
Operating Expenses Annual3.21
Operating Profit Annual0.29
Interest AnnualTBA
Depreciation0.00
Net Profit Annual0.21
Tax Annual0.08

Nexus Surgical and Medicare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.65
Cash Flow from Operations-0.41
Cash Flow from InvestingTBA
Cash Flow from FinancingTBA
Cash Flow at the End0.23

Nexus Surgical and Medicare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)8.65
PBIT Margin (%)8.65
PBT Margin (%)-855.90
Net PROFIT Margin (%)6.05
Return On Networth / Equity (%)3.84
Return On Networth /Employed (%)5.48
Return On Assets (%)45.63
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)7.54

Nexus Surgical and Medicare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.02
Total Current Assets Annual1.75
Non Current Assets Annual0.05
Total Shareholders Funds Annual0.57
Total Assets Annual1.81

Nexus Surgical and Medicare Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Nexus Surgical and Medicare Ltd has a market capitalization of 7.38 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Nexus Surgical and Medicare Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Nexus Surgical and Medicare Ltd recorded a total revenue of approximately 3.47 Cr marking a significant milestone in the company's financial performance.
Nexus Surgical and Medicare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.2% annually, respectively..
Nexus Surgical and Medicare Ltd's current PE ratio is 35.14.
Nexus Surgical and Medicare Ltd's ROCE averaged 109.7% from the FY ending March 2022 to 2024, with a median of 64.8%. It peaked at 213.0% in March 2022, reflecting strong capital efficiency over the period..
Nexus Surgical and Medicare Ltd's latest EBIT is Rs. 0.29 Cr, surpassing the average EBIT of Rs. 0.30 Cr over the 5 years..